List of SBIR/STTR awards granted to Lipella Pharmaceuticals
Lipella PharmaceuticalsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals in September, 2022 for $673,049.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK108397-04 | Phase II | 673,049 | September 20, 2022 | |||||||
A STTR Phase II contract was awarded to Lipella Pharmaceuticals in September, 2018 for $1,241,418.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42DK108397-02A1 | Phase II | 1,241,418 | September 20, 2018 | |||||||
A SBIR Phase I contract was awarded to Lipella Pharmaceuticals in August, 2017 for $210,558.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI134529-01 | Phase I | 210,558 | August 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals in May, 2017 for $998,466.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2SB1DK102247-04A1 | Phase II | 998,466 | May 5, 2017 | |||||||
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals in May, 2015 for $1,278,375.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK102247-02 | Phase II | 1,278,375 | May 1, 2015 | |||||||
A STTR Phase II contract was awarded to Lipella Pharmaceuticals in August, 2014 for $741,288.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42DK085733-04 | Phase II | 741,288 | August 1, 2014 | |||||||
A STTR Phase I contract was awarded to Lipella Pharmaceuticals in September, 2015 for $224,999.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DK108397-01 | Phase I | 224,999 | September 20, 2015 | |||||||
A SBIR Phase I contract was awarded to Lipella Pharmaceuticals for $222,176.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK102247-01 | Phase I | 222,176 | ||||||||
A STTR Phase II contract was awarded to Lipella Pharmaceuticals for $741,288.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42DK085733-04 | Phase II | 741,288 | ||||||||
A STTR Phase I contract was awarded to Lipella Pharmaceuticals for $740,688.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42DK085733-01 | Phase I | 740,688 | ||||||||
A SBIR Phase I contract was awarded to Lipella Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK083790-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals for $999,282.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK083790-02A1 | Phase II | 999,282 | ||||||||
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals for $750,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK074286-02A1 | Phase II | 750,000 | ||||||||
A SBIR Phase I contract was awarded to Lipella Pharmaceuticals for $99,617.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK074286-01A1 | Phase I | 99,617 |
